Helping mothers with BRCA+ genetic mutations communicate with their children about cancer risks
Improving Genetic Counseling for BRCA+ Mothers
This study is designed to help mothers with BRCA+ genetic mutations talk to their teenage and young adult kids about their genetic risks for cancer, making it easier for them to share this important information without feeling overwhelmed or anxious.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10792464 on NIH RePORTER |
What this research studies
This research focuses on supporting mothers who carry BRCA+ genetic mutations in effectively communicating their genetic status and associated cancer risks to their adolescent and young adult children. The study aims to address the psychological distress these mothers often face after receiving their test results, including anxiety and uncertainty about how to disclose this information. By developing a manualized psychosocial support program, the research seeks to provide evidence-based resources that help mothers navigate the complexities of family communication regarding inherited cancer susceptibility.
Who could benefit from this research
Good fit: Ideal candidates for this research are mothers who have tested positive for BRCA mutations and have adolescent or young adult children.
Not a fit: Patients who do not carry BRCA mutations or do not have children may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could empower mothers to communicate more effectively with their children about genetic risks, potentially leading to earlier detection and prevention of cancer.
How similar studies have performed: Previous research has shown success in developing psychosocial support programs for genetic counseling, indicating that this approach may be effective.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Tercyak, Kenneth — Georgetown University
- Study coordinator: Tercyak, Kenneth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.